Propanc Biopharma Plans to Purchase $100 Million Worth of Ethereum in the Next 12 Months
By: theblockbeats.news|2025/09/02 13:52:27
BlockBeats News, September 2nd, US-listed biopharmaceutical company Propanc Biopharma (PPCB) announced plans to buy $100 million worth of Ethereum in the next 12 months. Propanc Biopharma stated that this move will enhance its overall corporate strategy in various areas such as cryptocurrency investment, drug development, and asset acquisition.
U.S. publicly traded company Empery Digital has announced an additional purchase of 16.51 BTC, increasing its total holdings to 4,081.39 BTC.
Data: Avalon Labs has collected a total of $5.48 million in fees since June.
You may also like
Share
Gainers
Latest Crypto News
08:45
Unlimit Launches Stablecoin Decentralized Clearing Platform Stable.com
08:45
Crypto KOL paulwei has publicly shared his live trading on Hyperliquid, and recently placed a buy order in pyramid pattern to go long on BTC.
08:45
Monad Chain Meme Coin CHOG Recovers from Yesterday's Decline, Registers Nearly 60% Gain in 24 Hours
08:45
Securities and Futures Commission (SFC) Warns of Suspicious Investment Products "9M AI Stable Fund" and "9M AI Strategy Fund"
08:45
Shield Protocol: User deltatiger.eth has been attacked, losing approximately $330,000
Read more
Community
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]